CELG

Celgene Corporation News Headlines

$93.85
*  
0.58
0.62%
Get CELG Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead
9/3/2014 6:28:00 PM - Investor's Business Daily

Determining Celgene's Fair Value
9/3/2014 11:24:00 AM - Seeking Alpha

Is It Time to Buy Celgene Corporation's Stock?
9/3/2014 11:03:03 AM - Motley Fool

Bristol-Myers Returns Clazakizumab Rights, Alder Sinks - Analyst Blog
9/3/2014 11:02:00 AM - Zacks.com

Cramer's Mad Money - Fascinating Schisms (9/2/14)
9/3/2014 6:17:00 AM - Seeking Alpha

Bristol-Myers/Pfizer's Eliquis Encourages in VTE Analysis - Analyst Blog
9/2/2014 6:50:00 PM - Zacks.com

IBB, CELG, BIIB, ALXN: ETF Outflow Alert
9/2/2014 11:18:23 AM - BNK Invest

Biotechnology, Oil And Brazil ETFs To Watch This Week
9/2/2014 10:05:59 AM - Benzinga

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog
8/29/2014 6:30:00 PM - Zacks.com

Today's Market: Red Hot Biotech And Big Pharma Names To Watch
8/29/2014 8:22:00 AM - Seeking Alpha

#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict
8/28/2014 7:00:47 AM - Benzinga

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
8/27/2014 10:32:00 AM - Zacks.com

Why Celgene Stock Is Still A Good Investment Opportunity
8/26/2014 9:05:00 AM - Seeking Alpha

3 Reasons Celgene Corporation's Stock Could Fall
8/26/2014 8:49:24 AM - Motley Fool

#PreMarket Primer: Monday, August 25: Tension In Ukraine Runs High On Independence Day
8/25/2014 7:23:25 AM - Benzinga

Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog
8/22/2014 5:35:00 PM - Zacks.com

Cramer's Mad Money - 12 Stocks That Have Performed Better Than Google (8/21/14)
8/22/2014 6:22:00 AM - Seeking Alpha

Bull of the Day: Epizyme (EPZM) - Bull of the Day
8/22/2014 1:31:00 AM - Zacks.com

Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments - Analyst Blog
8/21/2014 5:20:00 PM - Zacks.com

Bull of the Day: Epizyme (EPZM) - Bull of the Day
8/21/2014 12:31:00 PM - Investopedia

#PreMarket Primer: Thursday, August 21: Tension Between Russia And The West Mounting
8/21/2014 6:40:45 AM - Benzinga

Emergent BioSolutions, MorphoSys Tie Up on Cancer Candidate - Analyst Blog
8/20/2014 6:08:00 PM - Zacks.com

Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog
8/19/2014 1:20:00 PM - Zacks.com

Noteworthy ETF Outflows: IYH, AMGN, BIIB, CELG
8/19/2014 11:03:17 AM - BNK Invest

Celgene's Phase II Trial Of REVLIMID With R-CHOP Shows Positive Results
8/19/2014 7:53:00 AM - RTT News